At Myriad, we’re committed to partnering with genetic counselors in an effort to make genetic testing more accessible, affordable and easier to use for all patient populations,” said Susan Manley, ...
These posters will focus on KET01’s acute tolerability and its minimal impact on sleep ... is a global precision psychiatry biopharma company headquartered in Munich, Germany, pioneering personalized ...
Cellworks Group Inc., a leader in Personalized Therapy Decision Support and Precision Drug Development, today announced results from a study using Cellworks computational biosimulation to predict how ...
In the completed Phase 1/2a clinical trial (NCT03715985), assessing EVX-01 in combination with a PD-1 inhibitor, eight of twelve metastatic melanoma patients (67%) had objective clinical responses ...